STOCK TITAN

SeaStar Medical (ICU) Schedule 13G/A: Intracoastal-linked 9.99% stake disclosed

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

SeaStar Medical Holding Corporation reports that, as of March 31, 2026, the reporting parties may be deemed to beneficially own 443,253 shares of Common Stock, representing 9.99% of the class based on 3,993,719 shares outstanding as of March 24, 2026. The reported position consists of four warrants held by Intracoastal exercisable for 134,615, 134,615, 131,062 and 42,961 shares, and excludes additional warrants subject to blocker provisions. Without the blocker provisions, the reporting persons may have been deemed to beneficially own 534,285 shares.

Positive

  • None.

Negative

  • None.

Insights

Schedule 13G/A discloses a near-10% beneficial stake held through exercisable warrants.

The filing lists a combined beneficial position of 443,253 shares tied to four Intracoastal warrants and reports 3,993,719 shares outstanding as of March 24, 2026. The report emphasizes voting and dispositive power is shared among the reporting persons.

The filing also identifies blocker provisions that limit exercise above specified ownership caps; without those blockers the stake would be 534,285 shares. Subsequent disclosures may clarify whether exercises, voting coordination, or group membership change this position.

Beneficial ownership reported 443,253 shares as of <date>March 31, 2026</date>
Percent of class 9.99% based on 3,993,719 shares outstanding as of <date>March 24, 2026</date>
Shares outstanding used 3,993,719 shares as reported by the issuer as of <date>March 24, 2026</date>
Potential ownership without blockers 534,285 shares hypothetical aggregate if blocker provisions did not apply
Intracoastal Warrant 1 134,615 shares shares issuable upon exercise of Intracoastal Warrant 1
Intracoastal Warrant 4 42,961 shares shares issuable upon exercise of Intracoastal Warrant 4 (partial exclusion noted)
blocker provision regulatory
"Intracoastal Warrant 4 contains a blocker provision under which the holder...would result in beneficial ownership above 9.99%"
beneficial ownership regulatory
"each of the Reporting Persons may have been deemed to have beneficial ownership of 443,253 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
warrant financial
"134,615 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal"
A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How many SeaStar Medical (ICU) shares do the reporting persons beneficially own?

They report beneficial ownership of 443,253 shares, which the filing states represents 9.99% of the Common Stock based on 3,993,719 shares outstanding as of March 24, 2026. The position is derived from exercisable warrants held by Intracoastal.

What securities form the reported position in the Schedule 13G/A for ICU?

The position consists of four Intracoastal warrants exercisable into 134,615, 134,615, 131,062, and 42,961 shares of Common Stock. The filing itemizes each warrant and the resulting share counts supporting the 9.99% figure.

Do any restrictions limit exercise of the Intracoastal warrants?

Yes. The filing states certain warrants contain blocker provisions preventing exercise to the extent it would cause beneficial ownership above 9.99% or 4.99%, and those restricted shares are excluded from the reported 443,253 total.

What would the ownership be without the blocker provisions?

The filing says that without the blocker provisions the reporting persons may have been deemed to beneficially own 534,285 shares. That alternative total aggregates additional shares currently excluded under the blocker terms.

Who are the reporting persons named in the filing for ICU?

The filing is made on behalf of Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. Addresses and citizenship are provided for each reporting person in the Schedule 13G/A.





81256L302

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Mitchell P. Kopin
Signature:/s/ Mitchell P. Kopin
Name/Title:Mitchell P. Kopin
Date:05/13/2026
Daniel B. Asher
Signature:/s/ Daniel B. Asher
Name/Title:Daniel B. Asher
Date:05/13/2026
Intracoastal Capital LLC
Signature:/s/ Mitchell P. Kopin
Name/Title:Mitchell P. Kopin, Manager
Date:05/13/2026